Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(Updates details from France, Italy, adds details on U.S. travelers, Midwest hospitals, economic outlook)* AstraZeneca, Novavax say their shots protect against Omicron* UK data suggests fewer hospitalisations compared with Delta* Do not extrapolat...
Read more(Adds comment from France, Germany)* AstraZeneca, Novavax say their shots protect from Omicron* UK data suggests fewer hospitalisations than from Delta* Don't extrapolate from similar SAfrican data -African CDC* WHO also urged caution about drawing f...
Read more* AstraZeneca, Novavax say their shots protect from Omicron* UK data suggests fewer hospitalisations than from Delta* Don't extrapolate from similar SAfrican data -African CDC* WHO also urged caution about drawing firm conclusionsBy James Macharia Ch...
Read more(Adds South African health worker study, Greece, Italy)* AstraZeneca, Novavax say their shots protect from Omicron* UK data suggests fewer hospitalisations than from Delta* Don't extrapolate from similar SAfrican data -African CDC* WHO also urged cau...
Read more(Adds CDC caution on South African data)* AstraZeneca, Novavax say their shots protect from Omicron* UK data suggests fewer hospitalisations than from Delta* Don't extrapolate from similar SAfrican data -African CDC* WHO also urged caution about draw...
Read more* AstraZeneca, Novavax say their shots protect from Omicron* UK data suggests fewer hospitalisations than from Delta* WHO has urged caution over any conclusions* Omicron has spread fast, many countries impose new curbsLONDON, Dec 23 (Reuters) - Two v...
Read more(Adds U.S. moves, FDA approval for Merck antiviral pill; freshens markets link)* AstraZeneca, Novavax say their shots protect from Omicron* UK data suggests fewer hospitalisations than from Delta* Don't extrapolate from similar SAfrican data -Africa...
Read more(Adds UK researcher comment, news from Russia, China)* AstraZeneca, Novavax say their shots protect from Omicron* UK data suggests fewer hospitalisations than from Delta* WHO has urged caution over drawing firm conclusions* Omicron has spread fast, m...
Read more* Antibody levels with booster similar to two doses against Delta* Protection also higher than those previously infected* Oxford researchers independent from vaccine partners (Adds more details on study, executive comment, background)By Pushkala Ar...
Read more(Adds detail from Oxford study)Dec 23 (Reuters) - A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab st...
Read more* Vaccine shortage spurred Nigeria to accept the doses* Rich nations had donated the shots with expiry looming* Destruction meant to spur residents' confidence in vaccine program* Recent surge in supply brings new distribution challenges*By Camillus...
Read more(Recasts and updates throughout with AstraZeneca statement)Dec 21 (Reuters) - AstraZeneca Plc said on Tuesday it is working with Oxford University to produce a vaccine for the Omicron coronavirus variant, joining other vaccine-makers who are looki...
Read more(Adds details from the report)Dec 21 (Reuters) - Oxford University and AstraZeneca Plc have begun work to produce an Omicron-targeted version of their coronavirus vaccine, the Financial Times reported https://www.ft.com/content/e61faf47-d563-4a87-8...
Read moreDec 21 (Reuters) - Oxford University and AstraZeneca Plc have begun work to produce an Omicron-targeted version of their coronavirus vaccine, the Financial Times reported https://www.ft.com/content/e61faf47-d563-4a87-8f0c-dcf7b8b28b43 on Tuesday. ...
Read more
AstraZeneca's treatment Ultomiris gets priority review from US FDA
Read more
Last checked at